GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chi Sheng Pharma & Biotech Co Ltd (ROCO:4111) » Definitions » Total Operating Expense

Chi Sheng Pharma & Biotech Co (ROCO:4111) Total Operating Expense : NT$307 Mil (TTM As of Mar. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Chi Sheng Pharma & Biotech Co Total Operating Expense?

Chi Sheng Pharma & Biotech Co's Total Operating Expense for the three months ended in Mar. 2025 was NT$78 Mil. Chi Sheng Pharma & Biotech Co's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was NT$307 Mil.

Chi Sheng Pharma & Biotech Co Total Operating Expense Historical Data

The historical data trend for Chi Sheng Pharma & Biotech Co's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chi Sheng Pharma & Biotech Co Total Operating Expense Chart

Chi Sheng Pharma & Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 247.36 237.52 268.68 281.89 298.24

Chi Sheng Pharma & Biotech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.97 74.93 72.77 80.58 78.41

Chi Sheng Pharma & Biotech Co Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$307 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chi Sheng Pharma & Biotech Co Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Chi Sheng Pharma & Biotech Co's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Chi Sheng Pharma & Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chi Sheng Pharma & Biotech Co Ltd (ROCO:4111) » Definitions » Total Operating Expense
Comparable Companies
ROCO:4116 ROCO:6543 ROCO:6527 ROCO:6730 ROCO:4150 ROCO:7575 ROCO:6518 ROCO:4115 ROCO:6493 TPE:1752 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
N/A
Address
No. 3, Shijian Road, Hsin Chu Industrial Park, Hsinchu County, Hukou, TWN, 30316
Website
http://www.cscp.com.tw
Chi Sheng Pharma & Biotech Co Ltd manufactures and distributes medical medicines and equipment in Taiwan. It offers injections, including hemodialysis solutions, amino acid injections, vitamin injections, and externally applied medicines.

Chi Sheng Pharma & Biotech Co Headlines

No Headlines